Zhongzhong Jiang Selected Research

dihydrofolate

8/2022

lncRNA DHFRL1‑4 knockdown attenuates cerebral ischemia/reperfusion injury by upregulating the levels of angiogenesis‑related genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhongzhong Jiang Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 10/2018
3	Glioma (Gliomas) 01/2022 - 10/2018
1	Brain Ischemia (Cerebral Ischemia) 08/2022
1	Edema (Dropsy) 08/2022
1	Infarction (Infarctions) 08/2022
1	Necrosis 08/2022
1	Reperfusion Injury 08/2022
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Cerebrospinal Fluid Leak 09/2019
1	Infections 09/2019
1	Intraoperative Complications 09/2019

Drug/Important Bio-Agent (IBA)

1	salicylhydroxamic acid (SHAM)IBA 08/2022
1	dihydrofolateIBA 08/2022
1	Glycogen Synthase (Synthase I)IBA 08/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022
1	Long Noncoding RNAIBA 08/2022
1	CXCR ReceptorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Bcl-2-Like Protein 11IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Tripartite Motif-Containing Protein 28IBA 01/2019
1	Co-Repressor ProteinsIBA 01/2019
1	Biological ProductsIBA 10/2018
1	MK 2206IBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2018

Therapy/Procedure

1	Bed Rest (Bedrest) 09/2019